Opinions Matthew McCall
GW Pharmaceuticals PLCGWPHTOP PICKJun 01, 2016
Matthew McCallOwned
$92.17
Stock price when the opinion was issued
Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
PAST TOP PICK
(Top Pick Jun 1/16, Up 7%) He bought and sold it a few different times in the last year. They make several drugs. They have several trials with positive news having come out in the last year. One or two new drugs will get approved in the next year. He still likes it, but keep in mind the aggressiveness that comes with it.
Matthew McCallOwned
Pharma & Healthcare
A UK company. They use synthetic cannabinoids to create drugs that are used to fight seizures and pain. This has been lumped into the cannabis/marijuana sector. Had their phase 3 updated results for a drug for seizures in children under 1 year of age. In the next month, there are 2 phase 3 trials that are coming in from the FDA, and he believes that 1, possibly 2 are going to be approved.